JPMorgan lowered the firm’s price target on Zoetis (ZTS) to $200 from $230 and keeps an Overweight rating on the shares post the Q3 report. The firm reduced estimates to reflect slower growth in 2025 and 2026 but says this is already priced into the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZTS: